Videos & Documents
University of Maryland Medicine Rounds highlights the multidisciplinary care for esophageal cancer at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.
The FDA has approved a study at the University of Maryland Greenebaum Comprehensive Cancer Center that will harness MRI-guided focused ultrasound to open the blood brain barrier in patients with malignant brain tumors.
Reengineering at the cellular level is transforming medicine, resulting in treatments – and in some cases, cures – for cancer, heart disease, diabetes, and neurological disorders.
Way back in the mid-2000s, researchers at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center recognized the need for an improvement in delivering radiotherapy to patients with early stage breast cancer.
T cell-based immunotherapy represents one of the most promising emerging treatments for advanced cancers.
Having the right tools to offer patients with brain tumors an optimal treatment can greatly preserve their qualities of life.
Transoral robotic surgery can benefit patients with a CUP by increasing detection rates of the occult tumor and improving treatment-related morbidity.
Dr. Joseph Friedberg explains why and how he offers surgical candidates pleurectomy/decortication (lung-sparing surgery) as a treatment for malignant pleural mesothelioma.
Mesothelioma cells are particularly susceptible to radiotherapy, and proton therapy allows a higher dosage of radiation more precisely to the patient’s pleural lining while sparing more of the heart, lungs, and esophagus.
Dr. Friedberg explains how surgery can be beneficial and explains intraoperative strategies to remove microscopic disease that can lengthen survival for patients with MPM.
Researchers like the University of Maryland Medical Center are exploring the use of MRI-ultrasound fusion and metabolic imaging to allow for targeted biopsy of suspicious tissues.
In this video, Ashkan Emadi, MD, PhD, discusses a promising checkpoint inhibitor called indoximod that could leave patients with dramatically lower levels of residual disease than standard chemotherapy...
A devastating diagnosis with deadly ovarian cancer recently brought a woman in her 40s to University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC).
With numerous historical anecdotes indicating that thermal therapy — incorporating heat into cancer-zapping treatments — was used by ancient Egyptians, it’s a fact that the University of Maryland helped steer the therapy in the modern age and continues
When a 51-year-old Washington, D.C.-area detective came to University of Maryland Marlene and Stewart Greenebaum Cancer Center with an advanced case of lymphoma, it was his last hope.